Publications by authors named "Zeliha Pala"

Claim this Profile
S
Sex-, feeding-, and circadian time-dependency of P-glycoprotein expression and activity - implications for mechanistic pharmacokinetics modeling.
Alper Okyar, Swati A Kumar, Elisabeth Filipski, Enza Piccolo, Narin Ozturk, Zeliha Pala

Sci Rep· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of abcc2 [multidrug resistance-associated protein (MRP) 2], abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexate.
Maria L H Vlaming, Anita van Esch, Evita van de Steeg, Zeliha Pala, Els Wagenaar

Drug Metab Dispos· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo.
Maria L H Vlaming, Anita van Esch, Zeliha Pala, Els Wagenaar, Koen van de Wetering

Mol Cancer Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivo.
Maria L H Vlaming, Zeliha Pala, Anita van Esch, Els Wagenaar, Dirk R de Waart

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Abcc2 (Mrp2) and Abcc3 (Mrp3) on the in vivo elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate.
Maria L H Vlaming, Zeliha Pala, Anita van Esch, Els Wagenaar, Olaf van Tellingen

Clin Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis